Substance abuse situation record: ketamine
Effects of Ketamine on Human Bladders and Its Possible Mechanisms
Brief Summary
This study is aimed to evaluate the relationship between ketamine abused and bladder dysfunction and its possible mechanisms.
Study Design
Study type: | OBSERVATIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 18 Years and older (Adult, Older Adult) |
Enrollment: | 44 (ACTUAL) |
Funded by: | Other |
Time Perspective: | Cross-Sectional |
Observational Model: | Case-Only |
Masking |
Clinical Trial Dates
Start date: | Mar 01, 2009 | |
---|---|---|
Primary Completion: | Dec 01, 2009 | ACTUAL |
Completion Date: | Dec 01, 2011 | ACTUAL |
Study First Posted: | Aug 12, 2009 | ESTIMATED |
Results First Posted: | Jan 14, 2016 | ESTIMATED |
Last Updated: | Dec 08, 2015 |
Sponsors / Collaborators
Lead Sponsor:
Taipei Medical University WanFang Hospital
Lead sponsor is responsible party
Responsible Party:
N/A
Location
Participant Groups
-
ketamine + Cystitis
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 18 |
Age Groups: | Adult / Older Adult |
Healthy Volunteers: | Yes |
Inclusion Criteria:
* Adult male or female
* Cystitis (the clinicians ruled out the causes of bacterial infection)
* Frequent micturition
* The clinicians are willing to sign the ICF
Exclusion Criteria:
* Suffers from the urinary system disease, is not suitable to carry on the urinary bladder biopsy sampling
* Suffers from other diseases, doctor recognized that is not suitable to carry on the sampling
* The clinicians are not willing to sign the ICF
* Adult male or female
* Cystitis (the clinicians ruled out the causes of bacterial infection)
* Frequent micturition
* The clinicians are willing to sign the ICF
Exclusion Criteria:
* Suffers from the urinary system disease, is not suitable to carry on the urinary bladder biopsy sampling
* Suffers from other diseases, doctor recognized that is not suitable to carry on the sampling
* The clinicians are not willing to sign the ICF
Primary Outcomes
Secondary Outcomes
-
Urinary Bladder Capacity 1 day
More Details
NCT Number: | NCT00957333 |
---|---|
Other IDs: | DOH98-NNB-1049 |
Study URL: | https://clinicaltrials.gov/study/NCT00957333 |
Last updated: Sep 29, 2023